{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:02:10Z","timestamp":1771333330192,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.ejphar.2009.09.061","type":"journal-article","created":{"date-parts":[[2009,10,10]],"date-time":"2009-10-10T08:47:36Z","timestamp":1255164456000},"page":"23-30","source":"Crossref","is-referenced-by-count":12,"title":["JY0691, a newly synthesized obovatol derivative, inhibits cell cycle progression of rat aortic smooth muscle cells through up-regulation of p21cip1"],"prefix":"10.1016","volume":"624","author":[{"given":"Ji-Yeon","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Kyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tack-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwan-Soo","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeo-Pyo","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Chae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.09.061_bib1","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1073\/pnas.89.17.7900","article-title":"Phosphorylation of the retinoblastoma protein by cdk2","volume":"89","author":"Akiyama","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2009.09.061_bib2","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1073\/pnas.90.13.5889","article-title":"Signal transduction via the MAP kinases: proceed at your own RSK","volume":"90","author":"Blenis","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2009.09.061_bib3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1749-6632.1995.tb26691.x","article-title":"Platelet-derivated growth factor. Distinct signal transduction pathways associated with migration versus proliferation","volume":"766","author":"Bornfeldt","year":"1995","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2009.09.061_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/01.ATV.0000125704.28058.a2","article-title":"Cell cycle-dependent regulation of smooth muscle cell activation","volume":"24","author":"Braun-Dullaeus","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2009.09.061_bib5","doi-asserted-by":"crossref","first-page":"29207","DOI":"10.1074\/jbc.272.46.29207","article-title":"CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation","volume":"272","author":"Brooks","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2009.09.061_bib6","first-page":"503","article-title":"Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture","volume":"177","author":"Chamley","year":"1997","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2009.09.061_bib7","doi-asserted-by":"crossref","first-page":"32023","DOI":"10.1016\/S0021-9258(18)31591-6","article-title":"Platelet-derived growth factor receptor signals","volume":"269","author":"Claesson-Welsh","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2009.09.061_bib8","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1073\/pnas.94.7.2776","article-title":"The cell cycle and cancer","volume":"94","author":"Collins","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2009.09.061_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0960-9822(98)70021-1","article-title":"G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts","volume":"8","author":"Connell-Crowley","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2009.09.061_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0962-8924(02)00043-0","article-title":"New roles for p21 and p27 cell-cycle inhibitors: a function of each cell compartment?","volume":"13","author":"Conqueret","year":"2003","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejphar.2009.09.061_bib11","first-page":"293","article-title":"New targets for viral cyclins","volume":"2","author":"Conqueret","year":"2003","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2009.09.061_bib12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/nm1102-1249","article-title":"Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies","volume":"8","author":"Dzau","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2009.09.061_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/381643a0","article-title":"Cell-cycle control and its watchman","volume":"381","author":"Jack","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2009.09.061_bib14","doi-asserted-by":"crossref","first-page":"51100","DOI":"10.1074\/jbc.M409080200","article-title":"Cdk4 is indispensable for postnatal proliferation of the anterior pituitary","volume":"279","author":"Jirawatnotai","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2009.09.061_bib15","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.bcp.2005.04.002","article-title":"Luteolin prevents PDGF-BB-induced proliferation of vascular smooth muscle cells by inhibition of PDGF beta-receptor phosphorylation","volume":"69","author":"Kim","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.09.061_bib16","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/ATVBAHA.109.190058","article-title":"Protective role of clusterin\/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells","volume":"29","author":"Kim","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2009.09.061_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/FJC.0b013e31819fd4cb","article-title":"Antiproliferative action of cudraflavone B, isolated from Cudrania tricuspidata, through the downregulation of pRb phosphorylation in aortic smooth muscle cell proliferation signaling","volume":"53","author":"Kim","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.09.061_bib18","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.5012\/bkcs.2007.28.9.1601","article-title":"Synthesis of obovatol derivatives and their preliminary evaluation as antitumor agents","volume":"28","author":"Lee","year":"2007","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.ejphar.2009.09.061_bib19","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1016\/j.bmc.2008.08.033","article-title":"Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis","volume":"16","author":"Lee","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2009.09.061_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2007.12.027","article-title":"Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-kappaB","volume":"582","author":"Lee","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.09.061_bib21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2009.09.061_bib22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0022-3565(24)37446-4","article-title":"Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation","volume":"28","author":"Lipson","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.09.061_bib23","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1101\/gad.9.8.935","article-title":"p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage","volume":"9","author":"Macleod","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2009.09.061_bib24","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1083\/jcb.111.5.2149","article-title":"PDGF ligand and receptor gene expression during repair of arterial injury","volume":"111","author":"Majesky","year":"1990","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2009.09.061_bib25","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.102.17.2124","article-title":"Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1)","volume":"102","author":"Marra","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.09.061_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccr.2005.05.006","article-title":"Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1)","volume":"7","author":"Martin","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2009.09.061_bib27","first-page":"225","article-title":"Structure and function of small arteries in hypertension","volume":"8","author":"Mulvany","year":"1990","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.ejphar.2009.09.061_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1007700629728","article-title":"Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo","volume":"13","author":"Myllarniemi","year":"1999","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2009.09.061_bib29","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1038\/sj.onc.1207532","article-title":"DNA damage-induced apoptosis","volume":"23","author":"Norbury","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2009.09.061_bib30","first-page":"73","article-title":"Cyclin D-dependent kinases, INK4 inhibitors and cancer","volume":"1602","author":"Orgeta","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2009.09.061_bib31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2009.09.061_bib32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1146\/annurev.ph.57.030195.004043","article-title":"Cell biology of atherosclerosis","volume":"57","author":"Ross","year":"1995","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2009.09.061_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.09.061_bib34","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1016\/S0021-9258(18)86937-X","article-title":"Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells","volume":"265","author":"Sachinidis","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2009.09.061_bib35","doi-asserted-by":"crossref","first-page":"8345","DOI":"10.1074\/jbc.271.14.8345","article-title":"Phorbol ester inhibits the phosphorylation of the retinoblastoma protein without suppressing cyclin D-associated kinase in vascular smooth muscle cells","volume":"271","author":"Sasaguri","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2009.09.061_bib36","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0735-1097(92)90389-5","article-title":"The restenosis paradigm revisited: an alternative proposal for cellular mechanisms","volume":"20","author":"Schwartz","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2009.09.061_bib37","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2009.09.061_bib38","first-page":"3689","article-title":"The Pezcoller lecture: cancer cell cycles revisited","volume":"60","author":"Sherr","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2009.09.061_bib39","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2009.09.061_bib40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/01.RES.75.4.650","article-title":"Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis","volume":"75","author":"Strauss","year":"1994","journal-title":"Circ Res."},{"key":"10.1016\/j.ejphar.2009.09.061_bib41","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/01.CIR.101.17.2022","article-title":"Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smoothmuscle cell proliferation","volume":"101","author":"Tanner","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.09.061_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2005.02.007","article-title":"Roxithromycin is an inhibitor of human coronary artery smooth muscle cells proliferation: a potential ability to prevent coronary heart disease","volume":"182","author":"Tomita","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2009.09.061_bib43","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1161\/01.CIR.96.11.4083","article-title":"Modulation of growth factor action: implications for the treatment of cardiovascular diseases","volume":"96","author":"Waltenberger","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.09.061_bib44","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/366701a0","article-title":"p21 is a universal inhibitor of cyclin kinases","volume":"366","author":"Xiong","year":"1993","journal-title":"Nature"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909008450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909008450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T17:52:52Z","timestamp":1739382772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299909008450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":44,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0014299909008450"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.09.061","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}